Biogen Bilan de santé
Santé financière contrôle des critères 6/6
Biogen has a total shareholder equity of $16.4B and total debt of $6.3B, which brings its debt-to-equity ratio to 38.5%. Its total assets and total liabilities are $28.3B and $12.0B respectively. Biogen's EBIT is $2.3B making its interest coverage ratio 11.9. It has cash and short-term investments of $1.7B.
Informations clés
38.5%
Ratio d'endettement
US$6.29b
Dette
| Ratio de couverture des intérêts | 11.9x |
| Argent liquide | US$1.70b |
| Fonds propres | US$16.36b |
| Total du passif | US$11.95b |
| Total des actifs | US$28.31b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analyse de la situation financière
Passif à court terme: 0R1B's short term assets ($6.8B) exceed its short term liabilities ($5.4B).
Passif à long terme: 0R1B's short term assets ($6.8B) exceed its long term liabilities ($6.5B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 0R1B's net debt to equity ratio (28.1%) is considered satisfactory.
Réduire la dette: 0R1B's debt to equity ratio has reduced from 42.5% to 38.5% over the past 5 years.
Couverture de la dette: 0R1B's debt is well covered by operating cash flow (33.8%).
Couverture des intérêts: 0R1B's interest payments on its debt are well covered by EBIT (11.9x coverage).